Biliary Cancer
Showing 1 - 25 of >10,000
Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)
Recruiting
- Cholangiocarcinoma Non-resectable
- Candonilimab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Aug 4, 2023
Liver and Biliary Cancer Patients Treated With PD-1 Combination
Active, not recruiting
- Hepatocellular Carcinoma
- Bile Duct Cancer
- [68Ga]FAPI PET/CT and [18F]FDG PET/CT
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 14, 2022
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
Recruiting
- Biliary Tract Cancer
-
Roma, Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
Jul 10, 2023
Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)
Not yet recruiting
- Advanced Biliary Tract Cancer
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
Apr 7, 2023
Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)
Active, not recruiting
- Biliary Tract Neoplasms
- +2 more
- Durvalumab + Gem/Cis
- Gem/Cis
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 30, 2023
Biliary Cancer Trial in San Francisco (Pembrolizumab, Sargramostim)
Completed
- Biliary Cancer
-
San Francisco, CaliforniaUniversity of California San Francisco
Jan 21, 2022
HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)
Not yet recruiting
- HER2-positive Colorectal Cancer
- HER2-positive Biliary Tract Cancer
- KN026
- +2 more
-
Beijing, State*, ChinaPeking University cancer hospital & institution
Aug 2, 2023
Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)
Not yet recruiting
- Advanced Biliary Tract Cancer
- (no location specified)
Apr 2, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
LIver, Biliary tRAct and pancReatic Cancers
Recruiting
- Liver Cancer
- +2 more
- Blood drawing
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023
Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)
Recruiting
- Advanced Biliary Tract Cancer
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 22, 2023
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -
Not yet recruiting
- Biliary Tract Cancer
- (no location specified)
Apr 26, 2023
Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Esophageal Cancer
- +10 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)
Recruiting
- Biliary Tract Neoplasms
- Immunotherapy
- Durvalumab
- +2 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Jul 6, 2023
Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)
Not yet recruiting
- Locally Advanced Biliary Tract Cancer
- Metastatic Biliary Tract Cancer
- Camrelizumab and Apatinib Plus GP
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Feb 15, 2023
GI Cancer Trial in Taoyuan (Frailty intervention measures)
Recruiting
- GI Cancer
- Frailty intervention measures
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Sep 22, 2023
Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)
Recruiting
- Biliary Tract Cancer
- +2 more
- Immune Checkpoint Inhibitors
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary
Recruiting
- Biliary Tract Cancer
- Blood drawing
-
Guangzhou, Guangdong, China
- +1 more
Dec 28, 2022
Pancreas Cancer Trial (mRNA expression)
Not yet recruiting
- Pancreas Cancer
- mRNA expression
- (no location specified)
Aug 8, 2022
Predict the Response of Biliary Tract Tumors to Immunotherapy
Recruiting
- Biliary Tract Tumor
- Cholangiocarcinoma
- Blood samples, tumor biopsy specimens will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 22, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023